These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10518091)

  • 1. Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway?
    Schmidt B
    J Pediatr; 1999 Oct; 135(4):526-8. PubMed ID: 10518091
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: The use of xanthines in treating apnea of prematurity.
    Morens DM
    Pediatrics; 1975 Oct; 56(4):617-9. PubMed ID: 1165973
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: The use of xanthines in treating apnea of prematurity.
    Kuzemko JA
    Pediatrics; 1976 Feb; 57(2):293. PubMed ID: 1250669
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylxanthine use for apnea of prematurity among an international cohort of neonatologists.
    Abu Jawdeh EG; O'Riordan M; Limrungsikul A; Bandyopadhyay A; Argus BM; Nakad PE; Supapannachart S; Yunis KA; Davis PG; Martin RJ
    J Neonatal Perinatal Med; 2013; 6(3):251-6. PubMed ID: 24246598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.
    Schmidt B
    Biol Neonate; 2005; 88(3):208-13. PubMed ID: 16210843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of plasma xanthine levels in the treatment of apnea in premature infants].
    Brazier JL; Renaud H; Ribon B; Faucon G; Sassard J
    Therapie; 1978; 33(3):341-55. PubMed ID: 684686
    [No Abstract]   [Full Text] [Related]  

  • 7. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000075. PubMed ID: 10796115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based methylxanthine use in the NICU.
    Spitzer AR
    Clin Perinatol; 2012 Mar; 39(1):137-48. PubMed ID: 22341542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The xanthine treatment of apnea of prematurity.
    Lucey JF
    Pediatrics; 1975 May; 55(5):584-6. PubMed ID: 1128983
    [No Abstract]   [Full Text] [Related]  

  • 10. Early childhood developmental follow-up of infants with GMH/IVH: effect of methylxanthine therapy.
    Ment LR; Scott DT; Ehrenkranz RA; Duncan CC
    Am J Perinatol; 1985 Jul; 2(3):223-7. PubMed ID: 4015773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interconversion of theophylline and caffeine in newborn infants.
    Bada HS; Khanna NN; Somani SM; Tin AA
    J Pediatr; 1979 Jun; 94(6):993-5. PubMed ID: 448555
    [No Abstract]   [Full Text] [Related]  

  • 12. Heart rate variability in premature neonates pre-and postmethylxanthine administration.
    Kibblewhite DP; Sleigh JW
    Paediatr Anaesth; 1996; 6(5):399-403. PubMed ID: 8880821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug treatment of apnoea in premature infants (author's transl)].
    Willard D; Mack G; Messer J; Klethi J
    Nouv Presse Med; 1981 Mar; 10(14):1143-5. PubMed ID: 6111783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of apnea in infants.
    Kriter KE; Blanchard J
    Clin Pharm; 1989 Aug; 8(8):577-87. PubMed ID: 2670399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of theophylline to caffeine in premature infants.
    Boutroy MJ; Vert P; Monin P; Royer RJ; Royer-Morrot MJ
    Lancet; 1979 Apr; 1(8120):830. PubMed ID: 86080
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma beta-endorphin concentration and xanthine treatment in apnea of prematurity.
    Sankaran K; Hindmarsh KW; Tan L; Kalapurackal M
    Clin Invest Med; 1993 Jun; 16(3):197-203. PubMed ID: 8365047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of blood transfusion on apnea frequency in growing premature infants.
    DeMaio JG; Harris MC; Deuber C; Spitzer AR
    J Pediatr; 1989 Jun; 114(6):1039-41. PubMed ID: 2723896
    [No Abstract]   [Full Text] [Related]  

  • 18. Summary proceedings from the apnea-of-prematurity group.
    Finer NN; Higgins R; Kattwinkel J; Martin RJ
    Pediatrics; 2006 Mar; 117(3 Pt 2):S47-51. PubMed ID: 16777822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental outcome of premature infants treated with theophylline.
    Nelson RM; Resnick MB; Holstrum WJ; Eitzman DV
    Dev Pharmacol Ther; 1980; 1(5):274-80. PubMed ID: 7438973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to an editorial concerning magnesium therapy in premature infants with apnea neonatorum.
    Caddell JL
    J Am Coll Nutr; 1988 Jun; 7(3):185-91. PubMed ID: 3292632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.